Cargando…

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke

This study evaluates concentrations of local cerebral recombinant tissue plasminogen activator during mechanical thrombectomy treatment in acute stroke.

Detalles Bibliográficos
Autores principales:	Essig, Fabian, Kollikowski, Alexander M., Müllges, Wolfgang, Stoll, Guido, Haeusler, Karl Georg, Schuhmann, Michael K., Pham, Mirko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941250/ https://www.ncbi.nlm.nih.gov/pubmed/33683294 http://dx.doi.org/10.1001/jamaneurol.2021.0065

Ejemplares similares

Immunohistological Analysis of Neutrophils and Neutrophil Extracellular Traps in Human Thrombemboli Causing Acute Ischemic Stroke
por: Essig, Fabian, et al.
Publicado: (2020)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Defining cerebral leukocyte populations in local ischemic blood samples from patients with hyperacute stroke
por: Zimmermann, Lena, et al.
Publicado: (2022)

Progression of cerebral infarction before and after thrombectomy is modified by prehospital pathways
por: Kollikowski, Alexander M, et al.
Publicado: (2022)

Danger-associated molecular patterns are locally released during occlusion in hyper-acute stroke
por: Schuhmann, Michael K., et al.
Publicado: (2021)

An intravascular perspective on hyper-acute neutrophil, T-cell and platelet responses: Similarities between human and experimental stroke
por: Stoll, Guido, et al.
Publicado: (2022)

Platelet Activation and Chemokine Release Are Related to Local Neutrophil-Dominant Inflammation During Hyperacute Human Stroke
por: Kollikowski, Alexander M., et al.
Publicado: (2021)

Safety and Effectiveness of the New Generation APERIO® Hybrid Stent-retriever Device in Large Vessel Occlusion Stroke
por: Vogt, Marius L., et al.
Publicado: (2021)

Immune Cells Invade the Collateral Circulation during Human Stroke: Prospective Replication and Extension
por: Strinitz, Marc, et al.
Publicado: (2021)

Distinct Alterations in Oxygenation, Ion Composition and Acid-Base Balance in Cerebral Collaterals During Large-Vessel Occlusion Stroke
por: Feick, Jörn, et al.
Publicado: (2023)

Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion
por: Haarmann, Axel, et al.
Publicado: (2023)

CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-Inflammation in Acute Stroke
por: Schuhmann, Michael K., et al.
Publicado: (2020)

Platelets and lymphocytes drive progressive penumbral tissue loss during middle cerebral artery occlusion in mice
por: Schuhmann, Michael K., et al.
Publicado: (2021)

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
por: Barba, Lorenzo, et al.
Publicado: (2023)

Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice
por: Schuhmann, Michael K., et al.
Publicado: (2019)

Blockade of Platelet Glycoprotein Ibα Augments Neuroprotection in Orai2-Deficient Mice during Middle Cerebral Artery Occlusion
por: Bieber, Michael, et al.
Publicado: (2022)

Infarct growth precedes cerebral thrombosis following experimental stroke in mice
por: Göb, Vanessa, et al.
Publicado: (2021)

Propagating Relationship of Cerebral Oximetric Volume and the Clinical Outcome of Recombinant Tissue Plasminogen Activator (r-TPA) Therapy on Acute Cerebral Ischemic Stroke Patients
por: Paybast, Sepideh, et al.
Publicado: (2019)

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator
por: Ong, Cheung-Ter, et al.
Publicado: (2017)

Therapeutic effect of recombinant tissue plasminogen activator on acute cerebral infarction at different times
por: Liu, Ming, et al.
Publicado: (2013)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Description of a Novel Phosphodiesterase (PDE)-3 Inhibitor Protecting Mice From Ischemic Stroke Independent From Platelet Function
por: Bieber, Michael, et al.
Publicado: (2019)

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
por: Yoneda, Yukihiro, et al.
Publicado: (2009)

Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator
por: Gowda, Vykuntaraju K, et al.
Publicado: (2017)

Ischemic stroke and heart failure: facts and numbers
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses
por: Bäumer, Wolfgang, et al.
Publicado: (2013)

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
por: Wardlaw, Joanna M, et al.
Publicado: (2012)

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers
por: Aparicio, Hugo J., et al.
Publicado: (2015)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Functional Outcome Measures of Recombinant Tissue Plasminogen Activator–Treated Stroke Patients in the Telestroke Technology
por: Gainey, Jordan, et al.
Publicado: (2018)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment
por: Liu, Yonge, et al.
Publicado: (2020)

Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure—the COGNITION.MATTERS-HF cohort study
por: Frey, Anna, et al.
Publicado: (2021)

Validity and Efficacy of Methods to Define Blood Brain Barrier Integrity in Experimental Ischemic Strokes: A Comparison of Albumin Western Blot, IgG Western Blot and Albumin Immunofluorescence
por: Franke, Maximilian, et al.
Publicado: (2021)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Electrical Stimulation of the Mesencephalic Locomotor Region Attenuates Neuronal Loss and Cytokine Expression in the Perifocal Region of Photothrombotic Stroke in Rats
por: Schuhmann, Michael K., et al.
Publicado: (2019)

Safety of tissue plasminogen activator factor in an acute stroke patient with two unruptured cerebral aneurysms
por: Sonbaa, Ali M., et al.
Publicado: (2018)

Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
por: Jung, Kee-Taig, et al.
Publicado: (2010)

Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
por: You, Shoujiang, et al.
Publicado: (2018)

Risk Factors Associated with Outcomes of Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
por: Tseng, Yi-Ju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ovsdfgskt7uqjdfkm2uc84oq3r